MEET THE EXPERTS IN
NEW IMPLANT TECHNOLOGY
PECTOREAL VISION
Our vision is to create natural and safe tissue-engineered implants, using our new implant technology, to improve patients’ wellbeing and quality of life.
Dr Prasad Sawadkar
Founder and CEO
Prasad is a surgical research fellow at Northwick Park Institute for Medical Research (The Griffin Institute), Northwick Park and St Mark’s Hospitals, London, and a lecturer (Hon) at Division of Surgery, University College London (UCL). He has completed his PhD in Surgery from UCL and trained in clinical research at Harvard Medical School.
In the past, he has developed a suture technique for tendon repair and patented tissue-engineered tendon, skin grafts and breast implants. He has won many national and international awards for his research such as at UCL, Tissue Engineering and Regenerative Medicine International Society (TERMIS) and Tissue and Cell Engineering Society UK (TCES).
He is an inventor of Pectoreal technology and working towards the commercialisation of new implant technology.
Professor Jonathan Knowles
Scientific Advisor
Jonathan is Professor of Biomaterials Science at University College London, a position he has held since 2003. His research covers a wide variety of materials and he has published extensively in the field. During his career he has also been involved with a number of professional organisations, as both a member and also supporting the organisations by taking an active role on the committees.
He is a Fellow of both the Royal Society of Chemistry and the Institute of Materials Minerals and Mining and has in the past served on the IoM3 London Materials Society committee. He was also elected as a Fellow of the Institute of Medical and Biological Engineers, in the USA.
His work has also given rise to a significant portfolio of patents, some of which were licensed out and some are currently moving towards first-in-human studies.
Professor Hae-Won Kim
International Scientific Advisor
Prof Hae-Won Kim received his PhD from the Seoul National University, South Korea, in 2002.
He is currently Full Professor and Director of the Institute of Tissue Regeneration Engineering (ITREN) (one of the top research institutes in South Korea) and leads Medical Research Center (MRC), and BK21+ Global Research Center for Regenerative Medicine. He serves as the editor-in-chief of the Journal of Tissue Engineering, associate editor of Frontiers in Bioengineering & Biotechnology, and Tissue Engineering & Regenerative Medicine, and is an editorial board member in Biomaterials, Bioengineering, and the Journal of Tissue Engineering & Regenerative Medicine, etc.
He has published over 460 peer-reviewed papers with a total of 28,500 citations, an h-index of 85, and he has 210 patents. His research interests include the development of therapeutic biomaterials for regenerative medicine.
Professor Ash Mosahebi
Clinical Advisor
Prof Mosahebi qualified at Guy's & St Thomas’s Medical school in London. His plastic surgical training was in London Deanery in some of the largest and busiest hospitals in the UK. He has had further specialist training in reconstructive and aesthetic surgery in New York and Belgium. He is a Consultant and Academic Lead at Royal Free Hospital, London. He is a Professor of Plastic Surgery at UCL.
He is an author of a number of publications and has lectured extensively worldwide. He is involved in pioneering research work on regenerating new tissues through new biomaterials and tissue engineering as well as clinical trials in innovative techniques in wound healing. He is on the editorial board of Aesthetic Surgery Journal, Hon Secretary of BAAPS, past President of the Royal Society of Medicine (plastic surgery section), and has served on the United Kingdom Specialist Advisory Committee for Plastic Surgery.
Prof Mosahebi has set up the world’s first Aesthetic University Faculty and is Director of the Aesthetic Master's programme UCL. He has served on an advisory panel for Health Education England regulations on non-invasive aesthetic treatments. His specialist fields are biotherapy and stem cell research, tissue rejuvenation and regeneration.
GET IN TOUCH TO INVEST
For more information on our new implant technology for natural breast implants, or to invest with us, contact Pectoreal today by email:
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.